CLINICAL-RESPONSE OF RHEUMATOID-ARTHRITIS (RA) TO ANTI-TNF-ALPHA (CA2) MONOCLONAL-ANTIBODY (MAB) IS RELATED TO ADMINISTERED DOSE AND PERSISTENCE OF CIRCULATING ANTIBODY
Rn. Maini et al., CLINICAL-RESPONSE OF RHEUMATOID-ARTHRITIS (RA) TO ANTI-TNF-ALPHA (CA2) MONOCLONAL-ANTIBODY (MAB) IS RELATED TO ADMINISTERED DOSE AND PERSISTENCE OF CIRCULATING ANTIBODY, Arthritis and rheumatism, 38(9), 1995, pp. 200-200